A two-part, open-label, cross-over study to assess the pharmacokinetics of GSK221149 [retosiban] following single oral doses of various modified release formulations and a solution in healthy adult subjects.
Phase of Trial: Phase I
Latest Information Update: 16 Mar 2012
At a glance
- Drugs Retosiban; Retosiban
- Indications Preterm labour
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 12 Oct 2008 Status changed from recruiting to discontinued.
- 21 May 2007 New trial record.